Skip to main content
. Author manuscript; available in PMC: 2020 Nov 11.
Published in final edited form as: JACC Cardiovasc Interv. 2019 Oct 16;12(21):2119–2129. doi: 10.1016/j.jcin.2019.06.019

Table 3.

primary and secondary outcomes of the study

Variable No AF N=40,149 Preexisting AF N=29,563 New-onset AF N=2,948 P value
30-day HF readmission 1.5 3.3 9.4 <0.001
30-day stroke admission 2.4 2.3 6.4 <0.001
30-day bleed admission 1.0 1.2 3.8 <0.001
30-day mortality 2.6 4.6 2.8 <0.001
New PPM in same TAVR admission 25.3 24.9 28.2 0.0004
Long-term follow up event rates, per 100 person-year
HF readmission 6.3 13.6 25.2 <0.0001
Any bleeding 3.1 7.7 12.4 <0.0001
Stroke 2.6 2.9 5.7 <0.0001
All-cause mortality 12.8 22.6 29.7 <0.0001